title: TMEM106B a novel risk factor for frontotemporal lobar degeneration.
abstract: Recently, the first genome-wide association (GWA) study in frontotemporal lobar degeneration (FTLD) identified common genetic variability at the TMEM106B gene on chromosome 7p21.3 as a potential important risk-modifying factor for FTLD with pathologic inclusions of TAR DNA-binding protein (FTLD-TDP), the most common pathological subtype in FTLD. To gather additional evidence for the implication of TMEM106B in FTLD risk, multiple replication studies in geographically distinct populations were set up. In this review, we revise all recent replication and follow-up studies of the FTLD-TDP GWA study and summarize the growing body of evidence that establish TMEM106B as a bona fide risk factor for FTLD. With the TMEM106B gene, a new player has been identified in the pathogenic cascade of FTLD which could hold important implications for the future development of disease-modifying therapies.
authors: Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
authors: Julie
authors: J
authors: van der Zee
authors: Christine
authors: C
authors: Van Broeckhoven
references: Brain. 2011 Mar;134(Pt 3):808-15
references: 21354975
references: Brain. 2009 Mar;132(Pt 3):583-91
references: 19158106
references: Arch Neurol. 2007 Oct;64(10):1436-46
references: 17923627
references: J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):196-203
references: 20562461
references: Neurology. 2008 Oct 14;71(16):1235-9
references: 18768919
references: Neurology. 2006 Mar 28;66(6):839-44
references: 16421333
references: Nat Genet. 2009 Dec;41(12):1308-12
references: 19915575
references: Trends Genet. 2008 Apr;24(4):186-94
references: 18328591
references: Biomark Med. 2010 Feb;4(1):37-50
references: 20387302
references: Brain. 2006 Apr;129(Pt 4):868-76
references: 16495328
references: Neurology. 2009 May 12;72(19):1669-76
references: 19433740
references: Acta Neuropathol. 2011 Mar;121(3):373-80
references: 21104415
references: BMC Neurol. 2008 Aug 29;8:32
references: 18755042
references: Nat Genet. 2009 Oct;41(10):1083-7
references: 19734901
references: Nat Genet. 2009 Oct;41(10):1088-93
references: 19734902
references: Eur J Hum Genet. 2008 Apr;16(4):471-9
references: 18197194
references: Neurology. 2011 Feb 1;76(5):467-74
references: 21178100
references: Eur J Hum Genet. 2008 Feb;16(2):140-2
references: 18043718
references: Nat Genet. 2010 Mar;42(3):234-9
references: 20154673
references: Arch Neurol. 2010 May;67(5):606-16
references: 20457961
references: Nature. 2006 Aug 24;442(7105):920-4
references: 16862115
references: Arch Neurol. 2011 May;68(5):581-6
references: 21220649
references: Nat Genet. 2009 Oct;41(10):1094-9
references: 19734903
references: Neurobiol Aging. 2011 Apr;32(4):758.e1-7
references: 21257233
references: Ann Neurol. 2009 May;65(5):603-9
references: 19288468